http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2274434-C1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-008 |
| filingDate | 2004-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2006-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc6fa13f5c4c5535884ae8d71ad7a551 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1dae20432c53dbe3bbcbe319a0d43d70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39560eba47de43bc4265e14e26e1bfa8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9d7b706ef630feee90819fe70dae8f0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eca41a235cacd235cea82596695ccc49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c30c5a8add762b16ac2cea1ba679105f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8576bdfba3b00fad52b4e56af52091e9 |
| publicationDate | 2006-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2274434-C1 |
| titleOfInvention | Method for removing intraocular neoplasms |
| abstract | FIELD: medicine. n SUBSTANCE: method involves carrying out vitrectomy, retinotomy and exposing the intraocular neoplasm. Chlorine row photosensibilizer is intrastromally introduced at a dose of 0.8-1.1 mg/kg during 10 min. Fluorescent spectral diagnostic examination of the neoplasm in 20-30 min. When detecting fluorescence, the neoplasm is intravitreally exposed to laser radiation at wavelength corresponding to maximum light radiation absorption by the photosensibilizer with energy density being equal to 100-120 J/cm 2 . Irradiation proceeds field-by-field moving in circles from periphery to the center with neighboring fields overlap equal to 5% of area. Next to it, thermal therapy is applied to the neoplasm in field-by-field mode circularly moving from periphery to the center. Intraocular neoplasm is then intravitreally removed and retina is smoothed by applying perfluororganic substance and delimiting endolaser coagulation of retinotomy zone is carried out. Photosensibilizer is repeatedly intravenously introduced 7-14 days later and fluorescent spectral diagnostic examination of removed neoplasm zone is carried out. Fluorescence areas are intravitreally irradiated with laser radiation having wavelength corresponding to maximum light radiation absorption by the photosensibilizer with energy density being equal to 80-100 J/cm 2 . Then, the perfluororganic substance is substituted for silicon oil. n EFFECT: complete removal of neoplasm; reduced risk of viable tumor cells being retained in operation field; excluded tumor cells dissemination in performing operation; reduced risk of neoplasm recurrence. n 2 cl |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2596869-C1 |
| priorityDate | 2004-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.